The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinicopathologic and genomic characteristics of patients with advanced ovarian, breast, and prostate cancer treated with poly (ADP-ribose) polymerase inhibitors (PARPi) in a real-world setting.
 
Marko Velimirovic
Stock and Other Ownership Interests - Abbvie; Amgen
 
Teodora Kuzmanovic
No Relationships to Disclose
 
Maedeh Zokaei Nikoo
No Relationships to Disclose
 
Lesil Brihn
No Relationships to Disclose
 
Vicky Konig
No Relationships to Disclose
 
Tejuana Watson
No Relationships to Disclose
 
Teana Austin
No Relationships to Disclose
 
Lauren Bokovitz
No Relationships to Disclose
 
Tapas Ranjan Behera
No Relationships to Disclose
 
Gabriel Savage
No Relationships to Disclose
 
Megan Kilbane
No Relationships to Disclose
 
Elizabeth M. Azzato
No Relationships to Disclose
 
Zheng Jin Tu
No Relationships to Disclose
 
Wen Wee Ma
Consulting or Advisory Role - Kodikaz Therapeutic Solutions
Research Funding - Actuate Therapeutics (Inst); Athenex (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); CUE Biopharma (Inst); Elucida Oncology (Inst); Genentech (Inst); Ipsen (Inst); Jacobio (Inst); Merus (Inst); Repare Therapeutics (Inst); Sun Pharma (Inst)
 
Roberto Vargas
No Relationships to Disclose
 
Jacob Miller
No Relationships to Disclose
 
Emrullah Yilmaz
Consulting or Advisory Role - Astellas Pharma
 
Ying Ni
No Relationships to Disclose